Patterns of progressive atrophy vary with age in Alzheimer's disease patients

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 01, 2018
Source ID
10.1016/j.neurobiolaging.2017.11.002

Entities

People

  • Cassidy M. Fiford
  • David M. Cash
  • Emily N. Manning
  • Geert Jan Biessels
  • Gerard R. Ridgway
  • Ian B. Malone
  • Jennifer Nicholas
  • Josephine Barnes
  • M. Jorge Cardoso
  • Marc Modat
  • Owen T. Carmichael
  • Sebastien Ourselin

Organizations

  • AbbVie
  • Alzheimer Society of Canada
  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • Alzheimer's Research UK
  • BioClinica
  • Biogen
  • Brain Research Trust
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eisai
  • Eli Lilly and Company
  • Engineering and Physical Sciences Research Council
  • GE HealthCare
  • Hoffmann-La Roche
  • Innogenetics
  • Johnson & Johnson
  • Laboratoires Servier
  • Lundbeck
  • Medical Research Council
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute for Health and Care Research
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • Pennington Biomedical Research Foundation
  • Perrigo Company Plc
  • Pfizer
  • Roche (United States)
  • Seventh Framework Programme
  • Takeda Pharmaceutical Company
  • UCLH/UCL Biomedical Research Centre
  • United States Department of Defense
  • Wellcome
  • Wolfson Foundation